InvestDashboard.com



Synergy Pharmaceuticals Inc. (SGYP)



$2.62
52 Week Low
$4.12
2017-04-28 15:34:08 MDT
$7.15
52 Week High

Basic Info

Healthcare
Sector
Drug Manufacturers - Other
Industry
Nasdaq
Stock Exchange
United States
Country

Market Cap: $917,010,000Small Cap (Between $200M and $2B)
Analyst Recommendation:2Analysts say: Buy. (1=Strong Buy, 5=Strong Sell)
Beta: 1.35 Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index.

Fundamentals

ForwardPE: Unknown
5 Yr Est Growth: Unknown
Yield: 0.00%
PEG-Y Ratio: N/A
Unknown PEG-Y ratio

Technicals

% Above 50 DayMA: -12.34%
% Above 200 DayMA: -23.42%
SGYP Performance 52 Weeks: 13.22%
S&P 500 Performance 52 Weeks: 13.50%
Downtrend is still intact: SGYP is below both 50 and 200 day Moving Averages. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High.
SGYP underperforming S&P 500 by -0.28% the last 52 Weeks.

Profile


More Valuation

Price To Book: 22.22
Not so great value. Low Price to Book means better value. A P/B value of 5 or less is great. But consider other metrics and maybe the growth and yield makes it worth it.
EV to EBITDA: -5.92
Unknown EV to EBITDA ratio

More Info

Field Value Average Comments
% Held By Insiders7.01% 17.28%Held by fewer than average Insiders.
% Held By Institutions46.70% 62.07%Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price?
Short % Of Float31.46% 07.02% Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards.
Debt to Equity0.60 1.08 More Conservative Financing. Each industry has different Debt/Equity standard. Higher than 1 means company is taking on more leverage.
Profit Margin %N/A-00.18%Unknown.
Operating Margin %N/A-05.28%Unknown.
Return on Equity %N/A-08.79%Unknown.
Return on Assets %-88.18%-01.29% Return on Assets less than average percent. Stock can do better than this?
Revenue Per Employee $N/A $883,096.70Unknown.
Price to Cash 11.14 5.52 Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio N/A 2.26Unknown.

Quick Thoughts

PROS:
  1. Analysts like this stock: 2 (1=Strong Buy, 5=Strong Sell)

  2. Debt To Equity is lower than 1: 0.60

CONS:
  1. Stock is Below Short Term 50DMA: -12.34%

  2. Stock is Below Long Term 200DMA: -23.42%

  3. Stock underperforming S&P 500 over last 52 weeks: -0.28%

  4. Price to Cash Ratio (11.14) is greater than average. Company has less cash as a percent of price than the average.

  5. Price to Book is over 10: 22.22

  6. Shorted more than average: 31.46%

  7. Return on Assets is negative: -88.18%


Headlines


Stock Chart


InvestDashboard.com SGYP: Synergy Pharmaceuticals Inc.

This page updated Thu Feb 1 22:00:01 MST 2018.